References
- Aji Alex MR, Chacko AJ, Jose S, Souto EB. (2011). Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 42:11–18
- Ali Khan A, Mudassir J, Mohtar N, Darwis Y. (2013). Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine 8:2733–44
- Caliph SM, Charman WN, Porter CJ. (2000). Effect of short-, medium-, and long-chain fatty acid based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 89:1073–84
- Charman WN, Porter CJH. (1996). Lipophilic prodrugs designed for intestinal lymphatic transport. Adv Drug Deliv Rev 19:149–69
- Dahmani FZ, Yang H, Zhou J, et al. (2012). Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. Eur J Pharm Sci 47:179–89
- Edwards GA, Porter CJ, Caliph SM, et al. (2001). Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev 50:45–60
- Faisal W, O'Driscoll CM, Griffin BT. (2010). Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport. J Pharm Pharmacol 62:323–31
- Fan Z, Wu J, Fang X, Sha X. (2013). A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons. Int J Pharm 445:141–7
- Field FJ, Mathur SN. (1995). Intestinal lipoprotein synthesis and secretion. Prog Lipid Res 34:185–98
- Gao Y, Wang Y, Ma Y, et al. (2009). Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf B Biointerfaces 71:306–14
- Griffin BT, O'Driscoll CM. (2006). A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol 58:917–25
- Han LM, Guo J, Zhang LJ, et al. (2006). Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123. Acta Pharmacol Sin 27:747–53
- Lane ME, Meaney CM, Gubbins R, et al. (1998). Correlation between permeability co-efficients in a perfused rat model and the CaCo-2 cell model. Eur J Pharm Sci 6:S24
- Le Dévédec F, Strandman S, Hildgen P, et al. (2013). PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole. Mol Pharm 10:3057–66
- Li GP, Yin L, Liu T, et al. (2009). Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure. Am J Cardiol 103:512–14
- Lu Y, Park K. (2013). Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 453:198–214
- Nam YS, Kang HS, Park JY, et al. (2003). New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: micellar characteristics and cellular uptake. Biomaterials 24:2053–9
- Nanjwade BK, Patel DJ, Udhani RA, Manvi FV. (2011). Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs. Sci Pharm 79:705–27
- Nishiyama N, Kataoka K. (2006). Nanostructured devices based on block copolymer assemblies for drug delivery: designing structures for enhanced drug function. Adv Polym Sci 193: 67–101
- O’Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 15:405–15
- Shahnaz G, Hartl M, Barthelmes J, et al. (2011). Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design. Eur J Pharm Biopharm 79:171–80
- Trotter PJ, Ho SY, Storch J. (1996). Fatty acid uptake by Caco-2 human intestinal cells. J Lipid Res 37:336–46
- Yáñez JA, Wang SW, Knemeyer IW, et al. (2011). Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev 63:923–42
- Yu C, He B, Xiong MH, et al. (2013). The effect of hydrophilic and hydrophobic structure of amphiphilic polymeric micelles on their transport in epithelial MDCK cells. Biomaterials 34:6284–98